{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T00:19:45Z","timestamp":1717460385319},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T00:00:00Z","timestamp":1716768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T00:00:00Z","timestamp":1716768000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s00393-024-01522-x","type":"journal-article","created":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T16:01:46Z","timestamp":1716825706000},"page":"363-375","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Die h\u00e4ufigsten Fiebersyndrome und autoinflammatorischen Erkrankungen im Erwachsenenalter","The most frequent febrile syndromes and autoinflammatory diseases in adulthood"],"prefix":"10.1007","volume":"83","author":[{"given":"Anne","family":"Pankow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Krusche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,27]]},"reference":[{"issue":"5","key":"1522_CR1","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1007\/s00108-023-01514-0","volume":"64","author":"I Kotter","year":"2023","unstructured":"Kotter\u00a0I, Krusche\u00a0M (2023) Inflammatory rheumatic diseases in migrants. Inn Med 64(5):426\u2013434. https:\/\/doi.org\/10.1007\/s00108-023-01514-0","journal-title":"Inn Med"},{"issue":"10","key":"1522_CR2","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1002\/art.24458","volume":"61","author":"E Ben-Chetrit","year":"2009","unstructured":"Ben-Chetrit\u00a0E, Touitou\u00a0I (2009) Familial mediterranean Fever in the world. Arthritis Rheum 61(10):1447\u20131453. https:\/\/doi.org\/10.1002\/art.24458","journal-title":"Arthritis Rheum"},{"issue":"7","key":"1522_CR3","doi-asserted-by":"publisher","first-page":"adv00091","DOI":"10.2340\/00015555-3427","volume":"100","author":"H Bonnekoh","year":"2020","unstructured":"Bonnekoh\u00a0H, Butze\u00a0M, Kallinich\u00a0T, Kambe\u00a0N, Kokolakis\u00a0G, Krause\u00a0K (2020) Spectrum of Genetic Autoinflammatory Diseases Presenting with Cutaneous Symptoms. Acta Derm Venereol 100(7):adv91. https:\/\/doi.org\/10.2340\/00015555-3427","journal-title":"Acta Derm Venereol"},{"key":"1522_CR4","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00393-017-0265-9","volume":"76","author":"T Kallinich","year":"2017","unstructured":"Kallinich\u00a0T, Orak\u00a0B, Wittkowski\u00a0H (2017) Rolle der Genetik beim famili\u00e4ren Mittelmeerfieber. Z\u00a0Rheumatol 76:303\u2013312. https:\/\/doi.org\/10.1007\/s00393-017-0265-9","journal-title":"Z Rheumatol"},{"issue":"4","key":"1522_CR5","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1136\/annrheumdis-2015-208690","volume":"75","author":"S Ozen","year":"2016","unstructured":"Ozen\u00a0S, Demirkaya\u00a0E, Erer\u00a0B et\u00a0al (2016) EULAR recommendations for the management of familial Mediterranean fever. Ann Rheum Dis 75(4):644\u2013651. https:\/\/doi.org\/10.1136\/annrheumdis-2015-208690","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"1522_CR6","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1136\/annrheumdis-2019-215048","volume":"78","author":"M Gattorno","year":"2019","unstructured":"Gattorno\u00a0M, Hofer\u00a0M, Federici\u00a0S et\u00a0al (2019) Classification criteria for autoinflammatory recurrent fevers. Ann Rheum Dis 78(8):1025\u20131032. https:\/\/doi.org\/10.1136\/annrheumdis-2019-215048","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"1522_CR7","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1007\/s00108-021-01220-9","volume":"62","author":"A Pankow","year":"2021","unstructured":"Pankow\u00a0A, Feist\u00a0E, Baumann\u00a0U, Kirschstein\u00a0M, Burmester\u00a0GR, Wagner\u00a0AD (2021) What is confirmed in the treatment of autoinflammatory fever diseases? Internist 62(12):1280\u20131289. https:\/\/doi.org\/10.1007\/s00108-021-01220-9","journal-title":"Internist"},{"issue":"16","key":"1522_CR8","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1056\/NEJM198604173141601","volume":"314","author":"D Zemer","year":"1986","unstructured":"Zemer\u00a0D, Pras\u00a0M, Sohar\u00a0E, Modan\u00a0M, Cabili\u00a0S, Gafni\u00a0J (1986) Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. N\u00a0Engl J Med 314(16):1001\u20131005. https:\/\/doi.org\/10.1056\/NEJM198604173141601","journal-title":"N Engl J Med"},{"key":"1522_CR9","doi-asserted-by":"publisher","first-page":"152211","DOI":"10.1016\/j.semarthrit.2023.152211","volume":"61","author":"Y Levinsky","year":"2023","unstructured":"Levinsky\u00a0Y, Azani\u00a0L, Shkalim Zemer\u00a0V et\u00a0al (2023) Adherence to colchicine prophylaxis among patients with familial Mediterranean fever treated with interleukin-1\u00a0inhibitors. Semin Arthritis Rheum 61:152211. https:\/\/doi.org\/10.1016\/j.semarthrit.2023.152211","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"1522_CR10","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13075-020-2120-7","volume":"22","author":"S Stewart","year":"2020","unstructured":"Stewart\u00a0S, Yang\u00a0KCK, Atkins\u00a0K, Dalbeth\u00a0N, Robinson\u00a0PC (2020) Adverse events during oral colchicine use: a\u00a0systematic review and meta-analysis of randomised controlled trials. Arthritis Res Ther 22(1):28. https:\/\/doi.org\/10.1186\/s13075-020-2120-7","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"1522_CR11","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s00393-021-01017-z","volume":"80","author":"Z Boyadzhieva","year":"2021","unstructured":"Boyadzhieva\u00a0Z, Ruffer\u00a0N, Krusche\u00a0M (2021) Colchicine: old medication with new benefits : Use in rheumatology and beyond. Z\u00a0Rheumatol 80(7):647\u2013657. https:\/\/doi.org\/10.1007\/s00393-021-01017-z","journal-title":"Z Rheumatol"},{"issue":"1","key":"1522_CR12","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s00393-018-0588-1","volume":"78","author":"T Kallinich","year":"2019","unstructured":"Kallinich\u00a0T, Blank\u00a0N, Braun\u00a0T et\u00a0al (2019) Evidence-based treatment recommendations for familial Mediterranean fever : A\u00a0joint statement by the Society for Pediatric and Adolescent Rheumatology and the German Society for Rheumatology. Z\u00a0Rheumatol 78(1):91\u2013101. https:\/\/doi.org\/10.1007\/s00393-018-0588-1","journal-title":"Z Rheumatol"},{"key":"1522_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-023-05351-0","author":"SO Cebeci","year":"2023","unstructured":"Cebeci\u00a0SO, Yildiz\u00a0M, Gunalp\u00a0A et\u00a0al (2023) The efficacy of a\u00a0single-dose anakinra injection during disease attack in pediatric familial Mediterranean fever. Rheumatol Int. https:\/\/doi.org\/10.1007\/s00296-023-05351-0","journal-title":"Rheumatol Int"},{"issue":"4","key":"1522_CR14","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00393-017-0265-9","volume":"76","author":"T Kallinich","year":"2017","unstructured":"Kallinich\u00a0T, Orak\u00a0B, Wittkowski\u00a0H (2017) Role of genetics in familial Mediterranean fever. Z\u00a0Rheumatol 76(4):303\u2013312. https:\/\/doi.org\/10.1007\/s00393-017-0265-9","journal-title":"Z Rheumatol"},{"issue":"4","key":"1522_CR15","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1136\/annrheumdis-2012-202932","volume":"73","author":"G Twig","year":"2014","unstructured":"Twig\u00a0G, Livneh\u00a0A, Vivante\u00a0A et\u00a0al (2014) Mortality risk factors associated with familial Mediterranean fever among a\u00a0cohort of 1.25 million adolescents. Ann Rheum Dis 73(4):704\u2013709. https:\/\/doi.org\/10.1136\/annrheumdis-2012-202932","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"1522_CR16","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1002\/art.22491","volume":"56","author":"I Aksentijevich","year":"2007","unstructured":"Aksentijevich\u00a0I, Putnam\u00a0CD, Remmers\u00a0EF et\u00a0al (2007) The clinical continuum of cryopyrinopathies: novel CIAS1 mutations in North American patients and a\u00a0new cryopyrin model. Arthritis Rheum 56(4):1273\u20131285. https:\/\/doi.org\/10.1002\/art.22491","journal-title":"Arthritis Rheum"},{"key":"1522_CR17","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/978-3-319-98605-0_19","volume-title":"extbook of Autoinflammation","author":"HMK-DJB Hoffman","year":"2019","unstructured":"Hoffman\u00a0HMK-DJB, Goldbach-Mansky\u00a0R (2019) Cryopyrine-Associated Periodic Syndromes (CAPS). In: Hashkes\u00a0PJ, Laxer\u00a0RM, Simon\u00a0A (Hrsg) extbook of Autoinflammation. Springer, Berlin\/Heidelberg,Germany, S\u00a0347\u2013365"},{"issue":"1","key":"1522_CR18","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s00393-021-01115-y","volume":"81","author":"M Krusche","year":"2022","unstructured":"Krusche\u00a0M, Kallinich\u00a0T (2022) Autoinflammation-differences between children and adults. Z\u00a0Rheumatol 81(1):45\u201354. https:\/\/doi.org\/10.1007\/s00393-021-01115-y","journal-title":"Z Rheumatol"},{"key":"1522_CR19","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.3389\/fimmu.2017.01410","volume":"8","author":"DM Rowczenio","year":"2017","unstructured":"Rowczenio\u00a0DM, Gomes\u00a0SM, Arostegui\u00a0JI et\u00a0al (2017) Late-Onset Cryopyrin-Associated Periodic Syndromes Caused by Somatic NLRP3 Mosaicism-UK Single Center Experience. Front Immunol 8:1410. https:\/\/doi.org\/10.3389\/fimmu.2017.01410","journal-title":"Front Immunol"},{"issue":"11","key":"1522_CR20","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1136\/annrheumdis-2017-212515","volume":"77","author":"E Ben-Chetrit","year":"2018","unstructured":"Ben-Chetrit\u00a0E, Gattorno\u00a0M, Gul\u00a0A et\u00a0al (2018) Consensus proposal for taxonomy and definition of the autoinflammatory diseases (AIDs): a\u00a0Delphi study. Ann Rheum Dis 77(11):1558\u20131565. https:\/\/doi.org\/10.1136\/annrheumdis-2017-212515","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"1522_CR21","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s00105-010-1932-9","volume":"61","author":"K Krause","year":"2010","unstructured":"Krause\u00a0K, Degener\u00a0F, Altrichter\u00a0S et\u00a0al (2010) Cold-induced urticaria and angioedema. Classification, diagnosis and therapy. Hautarzt 61(9):743\u2013749. https:\/\/doi.org\/10.1007\/s00105-010-1932-9","journal-title":"Hautarzt"},{"issue":"5","key":"1522_CR22","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1111\/jdv.13020","volume":"30","author":"VG Herbert","year":"2016","unstructured":"Herbert\u00a0VG, Ahmadi-Simab\u00a0K, Reich\u00a0K, Boer-Auer\u00a0A (2016) Neutrophilic urticarial dermatosis (NUD) indicating Cryopyrin-associated periodic syndrome associated with a\u00a0novel mutation of the NLRP3 gene. J\u00a0Eur Acad Dermatol Venereol 30(5):852\u2013853. https:\/\/doi.org\/10.1111\/jdv.13020","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"9","key":"1522_CR23","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1136\/annrheumdis-2015-207546","volume":"74","author":"NM ter Haar","year":"2015","unstructured":"ter Haar\u00a0NM, Oswald\u00a0M, Jeyaratnam\u00a0J et\u00a0al (2015) Recommendations for the management of autoinflammatory diseases. Ann Rheum Dis 74(9):1636\u20131644. https:\/\/doi.org\/10.1136\/annrheumdis-2015-207546","journal-title":"Ann Rheum Dis"},{"key":"1522_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10010128","author":"T Welzel","year":"2021","unstructured":"Welzel\u00a0T, Kuemmerle-Deschner\u00a0JB (2021) Diagnosis and Management of the Cryopyrin-Associated Periodic Syndromes (CAPS): What Do We Know Today? J\u00a0Clin Med. https:\/\/doi.org\/10.3390\/jcm10010128","journal-title":"J Clin Med"},{"issue":"6","key":"1522_CR25","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1002\/art.40055","volume":"69","author":"J Rodriguez-Smith","year":"2017","unstructured":"Rodriguez-Smith\u00a0J, Lin\u00a0YC, Tsai\u00a0WL et\u00a0al (2017) Cerebrospinal Fluid Cytokines Correlate With Aseptic Meningitis and Blood-Brain Barrier Function in Neonatal-Onset Multisystem Inflammatory Disease: Central Nervous System Biomarkers in Neonatal-Onset Multisystem Inflammatory Disease Correlate With Central Nervous System Inflammation. Arthritis Rheumatol 69(6):1325\u20131336. https:\/\/doi.org\/10.1002\/art.40055","journal-title":"Arthritis Rheumatol"},{"key":"1522_CR26","doi-asserted-by":"publisher","DOI":"10.1111\/imr.13292","author":"CD Putnam","year":"2023","unstructured":"Putnam\u00a0CD, Broderick\u00a0L, Hoffman\u00a0HM (2023) The discovery of NLRP3 and its function in cryopyrin-associated periodic syndromes and innate immunity. Immunol Rev. https:\/\/doi.org\/10.1111\/imr.13292","journal-title":"Immunol Rev"},{"issue":"12","key":"1522_CR27","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1136\/annrheumdis-2013-204184","volume":"73","author":"HJ Lachmann","year":"2014","unstructured":"Lachmann\u00a0HJ, Papa\u00a0R, Gerhold\u00a0K et\u00a0al (2014) The phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation: a\u00a0series of 158 cases from the Eurofever\/EUROTRAPS international registry. Ann Rheum Dis 73(12):2160\u20132167. https:\/\/doi.org\/10.1136\/annrheumdis-2013-204184","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1522_CR28","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1097\/BOR.0b013e32834dd2d5","volume":"24","author":"S Savic","year":"2012","unstructured":"Savic\u00a0S, Dickie\u00a0LJ, Battellino\u00a0M, McDermott\u00a0MF (2012) Familial Mediterranean fever and related periodic fever syndromes\/autoinflammatory diseases. Curr Opin Rheumatol 24(1):103\u2013112. https:\/\/doi.org\/10.1097\/BOR.0b013e32834dd2d5","journal-title":"Curr Opin Rheumatol"},{"issue":"5","key":"1522_CR29","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1097\/00005792-200209000-00002","volume":"81","author":"KM Hull","year":"2002","unstructured":"Hull\u00a0KM, Drewe\u00a0E, Aksentijevich\u00a0I et\u00a0al (2002) The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder. Medicine 81(5):349\u2013368. https:\/\/doi.org\/10.1097\/00005792-200209000-00002","journal-title":"Medicine"},{"issue":"20","key":"1522_CR30","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1056\/NEJMoa1706314","volume":"378","author":"F De Benedetti","year":"2018","unstructured":"De Benedetti\u00a0F, Gattorno\u00a0M, Anton\u00a0J et\u00a0al (2018) Canakinumab for the Treatment of Autoinflammatory Recurrent Fever Syndromes. N\u00a0Engl J Med 378(20):1908\u20131919. https:\/\/doi.org\/10.1056\/NEJMoa1706314","journal-title":"N Engl J Med"},{"issue":"1","key":"1522_CR31","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1136\/annrheumdis-2015-209031","volume":"76","author":"M Gattorno","year":"2017","unstructured":"Gattorno\u00a0M, Obici\u00a0L, Cattalini\u00a0M et\u00a0al (2017) Canakinumab treatment for patients with active recurrent or chronic TNF receptor-associated periodic syndrome (TRAPS): an open-label, phase\u00a0II study. Ann Rheum Dis 76(1):173\u2013178. https:\/\/doi.org\/10.1136\/annrheumdis-2015-209031","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"1522_CR32","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1002\/art.23475","volume":"58","author":"M Gattorno","year":"2008","unstructured":"Gattorno\u00a0M, Pelagatti\u00a0MA, Meini\u00a0A et\u00a0al (2008) Persistent efficacy of anakinra in patients with tumor necrosis factor receptor-associated periodic syndrome. Arthritis Rheum 58(5):1516\u20131520. https:\/\/doi.org\/10.1002\/art.23475","journal-title":"Arthritis Rheum"},{"issue":"5","key":"1522_CR33","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1136\/annrheumdis-2011-201268","volume":"72","author":"N Ter Haar","year":"2013","unstructured":"Ter Haar\u00a0N, Lachmann\u00a0H, Ozen\u00a0S et\u00a0al (2013) Treatment of autoinflammatory diseases: results from the Eurofever Registry and a\u00a0literature review. Ann Rheum Dis 72(5):678\u2013685. https:\/\/doi.org\/10.1136\/annrheumdis-2011-201268","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"1522_CR34","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1001\/jama.2022.24836","volume":"329","author":"DB Beck","year":"2023","unstructured":"Beck\u00a0DB, Bodian\u00a0DL, Shah\u00a0V et\u00a0al (2023) Estimated Prevalence and Clinical Manifestations of UBA1 Variants Associated With VEXAS Syndrome in a\u00a0Clinical Population. JAMA 329(4):318\u2013324. https:\/\/doi.org\/10.1001\/jama.2022.24836","journal-title":"JAMA"},{"issue":"27","key":"1522_CR35","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1056\/NEJMoa2026834","volume":"383","author":"DB Beck","year":"2020","unstructured":"Beck\u00a0DB, Ferrada\u00a0MA, Sikora\u00a0KA et\u00a0al (2020) Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory Disease. N\u00a0Engl J Med 383(27):2628\u20132638. https:\/\/doi.org\/10.1056\/NEJMoa2026834","journal-title":"N Engl J Med"},{"issue":"3","key":"1522_CR36","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/bjd.20805","volume":"186","author":"S Georgin-Lavialle","year":"2022","unstructured":"Georgin-Lavialle\u00a0S, Terrier\u00a0B, Guedon\u00a0AF et\u00a0al (2022) Further characterization of clinical and laboratory features in VEXAS syndrome: large-scale analysis of a\u00a0multicentre case series of 116 French patients. Br J Dermatol 186(3):564\u2013574. https:\/\/doi.org\/10.1111\/bjd.20805","journal-title":"Br J Dermatol"},{"issue":"10","key":"1522_CR37","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1002\/art.41743","volume":"73","author":"MA Ferrada","year":"2021","unstructured":"Ferrada\u00a0MA, Sikora\u00a0KA, Luo\u00a0Y et\u00a0al (2021) Somatic Mutations in UBA1 Define a\u00a0Distinct Subset of Relapsing Polychondritis Patients With VEXAS. Arthritis Rheumatol 73(10):1886\u20131895. https:\/\/doi.org\/10.1002\/art.41743","journal-title":"Arthritis Rheumatol"},{"issue":"8","key":"1522_CR38","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1136\/annrheumdis-2021-220089","volume":"80","author":"N Tsuchida","year":"2021","unstructured":"Tsuchida\u00a0N, Kunishita\u00a0Y, Uchiyama\u00a0Y et\u00a0al (2021) Pathogenic UBA1 variants associated with VEXAS syndrome in Japanese patients with relapsing polychondritis. Ann Rheum Dis 80(8):1057\u20131061. https:\/\/doi.org\/10.1136\/annrheumdis-2021-220089","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"1522_CR39","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1002\/art.41992","volume":"74","author":"F Muratore","year":"2022","unstructured":"Muratore\u00a0F, Marvisi\u00a0C, Castrignano\u00a0P et\u00a0al (2022) VEXAS Syndrome: A\u00a0Case Series From a\u00a0Single-Center Cohort of Italian Patients With Vasculitis. Arthritis Rheumatol 74(4):665\u2013670. https:\/\/doi.org\/10.1002\/art.41992","journal-title":"Arthritis Rheumatol"},{"key":"1522_CR40","doi-asserted-by":"publisher","first-page":"108996","DOI":"10.1016\/j.clim.2022.108996","volume":"238","author":"H Matsumoto","year":"2022","unstructured":"Matsumoto\u00a0H, Asano\u00a0T, Tsuchida\u00a0N et\u00a0al (2022) Behcet\u2019s disease with a\u00a0somatic UBA1 variant:Expanding spectrum of autoinflammatory phenotypes of VEXAS syndrome. Clin Immunol 238:108996. https:\/\/doi.org\/10.1016\/j.clim.2022.108996","journal-title":"Clin Immunol"},{"issue":"22","key":"1522_CR41","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1056\/NEJMc2102124","volume":"384","author":"DB Beck","year":"2021","unstructured":"Beck\u00a0DB, Grayson\u00a0PC, Kastner\u00a0DL (2021) Mutant UBA1 and Severe Adult-Onset Autoinflammatory Disease. Reply. N\u00a0Engl J Med 384(22):2164\u20132165. https:\/\/doi.org\/10.1056\/NEJMc2102124","journal-title":"N Engl J Med"},{"key":"1522_CR42","unstructured":"Betrains AJV, Dieudonne Y, Dion J, Lazaro E, De Moreuil C, Ardois S, Grosleron S, Arlet J, Durel C, Delaval L, Audia S, Golden C, Nicolas B, Langlois V, Perlat A, Vandergheynst F, Moulinet T, Samson M, Blockmans D, Kosmider O, Georgin-Lavialle S, Mekinian A, Terrier B Abnormalities Detected with [18F]-FDG-PET\/CT Imaging in VEXAS Syndrome [abstract. https:\/\/acrabstracts.org\/abstract\/abnormalities-detected-with-18f-fdg-pet-ct-imaging-in-vexas-syndrome\/ (Arthritis Rheumatol 2023;75 (suppl 9))"},{"key":"1522_CR43","doi-asserted-by":"publisher","first-page":"107245","DOI":"10.1016\/j.rmed.2023.107245","volume":"213","author":"M Casal Moura","year":"2023","unstructured":"Casal Moura\u00a0M, Baqir\u00a0M, Tandon\u00a0YK et\u00a0al (2023) Pulmonary manifestations in VEXAS syndrome. Respir Med 213:107245. https:\/\/doi.org\/10.1016\/j.rmed.2023.107245","journal-title":"Respir Med"},{"issue":"4","key":"1522_CR44","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s11239-021-02608-y","volume":"53","author":"TM Oo","year":"2022","unstructured":"Oo\u00a0TM, Koay\u00a0JTJ, Lee\u00a0SF, Lee\u00a0SMS, Lim\u00a0XR, Fan\u00a0BE (2022) Thrombosis in VEXAS syndrome. J\u00a0Thromb Thrombolysis 53(4):965\u2013970. https:\/\/doi.org\/10.1007\/s11239-021-02608-y","journal-title":"J Thromb Thrombolysis"},{"key":"1522_CR45","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2023-003332","author":"N Ruffer","year":"2023","unstructured":"Ruffer\u00a0N, Krusche\u00a0M (2023) VEXAS syndrome: a\u00a0diagnostic puzzle. RMD Open. https:\/\/doi.org\/10.1136\/rmdopen-2023-003332","journal-title":"RMD Open"},{"issue":"5","key":"1522_CR46","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/j.jaci.2023.02.017","volume":"151","author":"A Bruno","year":"2023","unstructured":"Bruno\u00a0A, Gurnari\u00a0C, Alexander\u00a0T et\u00a0al (2023) Autoimmune manifestations in VEXAS: Opportunities for integration and pitfalls to interpretation. J\u00a0Allergy Clin Immunol 151(5):1204\u20131214. https:\/\/doi.org\/10.1016\/j.jaci.2023.02.017","journal-title":"J Allergy Clin Immunol"},{"issue":"26","key":"1522_CR47","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.1182\/blood.2021010811","volume":"137","author":"C Gurnari","year":"2021","unstructured":"Gurnari\u00a0C, Pagliuca\u00a0S, Durkin\u00a0L et\u00a0al (2021) Vacuolization of hematopoietic precursors: an enigma with multiple etiologies. Blood 137(26):3685\u20133689. https:\/\/doi.org\/10.1182\/blood.2021010811","journal-title":"Blood"},{"issue":"11","key":"1522_CR48","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1038\/s41409-022-01774-8","volume":"57","author":"C Gurnari","year":"2022","unstructured":"Gurnari\u00a0C, McLornan\u00a0DP (2022) Update on VEXAS and role of allogeneic bone marrow transplant: Considerations on behalf of the Chronic Malignancies Working Party of the EBMT. Bone Marrow Transplant 57(11):1642\u20131648. https:\/\/doi.org\/10.1038\/s41409-022-01774-8","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"1522_CR49","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1111\/bjh.17930","volume":"196","author":"BA Patel","year":"2022","unstructured":"Patel\u00a0BA, Young\u00a0NS (2022) Towards treatments for VEXAS. Br J Haematol 196(4):804\u2013805. https:\/\/doi.org\/10.1111\/bjh.17930","journal-title":"Br J Haematol"},{"key":"1522_CR50","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kead240","author":"Z Boyadzhieva","year":"2023","unstructured":"Boyadzhieva\u00a0Z, Ruffer\u00a0N, Kotter\u00a0I, Krusche\u00a0M (2023) How to treat VEXAS-Syndrome: a\u00a0systematic review on effectiveness and safety of current treatment strategies. Rheumatology. https:\/\/doi.org\/10.1093\/rheumatology\/kead240","journal-title":"Rheumatology"},{"issue":"4","key":"1522_CR51","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1111\/bjh.17893","volume":"196","author":"T Comont","year":"2022","unstructured":"Comont\u00a0T, Heiblig\u00a0M, Riviere\u00a0E et\u00a0al (2022) Azacitidine for patients with Vacuoles, E1 Enzyme, X\u2011linked, Autoinflammatory, Somatic syndrome (VEXAS) and myelodysplastic syndrome: data from the French VEXAS registry. Br J Haematol 196(4):969\u2013974. https:\/\/doi.org\/10.1111\/bjh.17893","journal-title":"Br J Haematol"},{"issue":"22","key":"1522_CR52","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1056\/NEJMc2102124","volume":"384","author":"A Diarra","year":"2021","unstructured":"Diarra\u00a0A, Duployez\u00a0N, Terriou\u00a0L (2021) Mutant UBA1 and severe adult-onset autoinflammatory disease. N\u00a0Engl J Med 384(22):2163\u20132164. https:\/\/doi.org\/10.1056\/NEJMc2102124","journal-title":"N Engl J Med"},{"key":"1522_CR53","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18488","author":"A Al-Hakim","year":"2022","unstructured":"Al-Hakim\u00a0A, Poulter\u00a0JA, Mahmoud\u00a0D et\u00a0al (2022) Allogeneic haematopoietic stem cell transplantation for VEXAS syndrome: UK experience. Br J Haematol. https:\/\/doi.org\/10.1111\/bjh.18488","journal-title":"Br J Haematol"},{"key":"1522_CR54","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-224819","author":"B de Valence","year":"2023","unstructured":"de Valence\u00a0B, Delaune\u00a0M, Nguyen\u00a0Y et\u00a0al (2023) Serious infections in patients with VEXAS syndrome: data from the French VEXAS registry. Ann Rheum Dis. https:\/\/doi.org\/10.1136\/ard-2023-224819","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"1522_CR55","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41584-018-0081-x","volume":"14","author":"E Feist","year":"2018","unstructured":"Feist\u00a0E, Mitrovic\u00a0S, Fautrel\u00a0B (2018) Mechanisms, biomarkers and targets for adult-onset Still\u2019s disease. Nat Rev Rheumatol 14(10):603\u2013618. https:\/\/doi.org\/10.1038\/s41584-018-0081-x","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"1522_CR56","first-page":"343","volume":"35","author":"EM Behrens","year":"2008","unstructured":"Behrens\u00a0EM, Beukelman\u00a0T, Gallo\u00a0L et\u00a0al (2008) Evaluation of the presentation of systemic onset juvenile rheumatoid arthritis: data from the Pennsylvania Systemic Onset Juvenile Arthritis Registry (PASOJAR). J\u00a0Rheumatol 35(2):343\u2013348 (https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18085728)","journal-title":"J Rheumatol"},{"issue":"7","key":"1522_CR57","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1136\/ard.54.7.587","volume":"54","author":"G Magadur-Joly","year":"1995","unstructured":"Magadur-Joly\u00a0G, Billaud\u00a0E, Barrier\u00a0JH et\u00a0al (1995) Epidemiology of adult Still\u2019s disease: estimate of the incidence by a\u00a0retrospective study in west France. Ann Rheum Dis 54(7):587\u2013590. https:\/\/doi.org\/10.1136\/ard.54.7.587","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"1522_CR58","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/MD.0000000000000021","volume":"93","author":"M Gerfaud-Valentin","year":"2014","unstructured":"Gerfaud-Valentin\u00a0M, Maucort-Boulch\u00a0D, Hot\u00a0A et\u00a0al (2014) Adult-onset still disease: manifestations, treatment, outcome, and prognostic factors in 57\u00a0patients. Medicine 93(2):91\u201399. https:\/\/doi.org\/10.1097\/MD.0000000000000021","journal-title":"Medicine"},{"issue":"1","key":"1522_CR59","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/ncprheum0681","volume":"4","author":"LD Church","year":"2008","unstructured":"Church\u00a0LD, Cook\u00a0GP, McDermott\u00a0MF (2008) Primer: inflammasomes and interleukin 1beta in inflammatory disorders. Nat Clin Pract Rheumatol 4(1):34\u201342. https:\/\/doi.org\/10.1038\/ncprheum0681","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"7","key":"1522_CR60","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s00393-020-00779-2","volume":"79","author":"D Foll","year":"2020","unstructured":"Foll\u00a0D, Wittkowski\u00a0H, Hinze\u00a0C (2020) Still\u2019s disease as biphasic disorder : Current knowledge on pathogenesis and novel treatment approaches. Z\u00a0Rheumatol 79(7):639\u2013648. https:\/\/doi.org\/10.1007\/s00393-020-00779-2","journal-title":"Z Rheumatol"},{"issue":"5","key":"1522_CR61","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.berh.2008.08.006","volume":"22","author":"B Fautrel","year":"2008","unstructured":"Fautrel\u00a0B (2008) Adult-onset Still disease. Best Pract Res Clin Rheumatol 22(5):773\u2013792. https:\/\/doi.org\/10.1016\/j.berh.2008.08.006","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"6","key":"1522_CR62","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1097\/01.md.0000188009.47085.76","volume":"84","author":"JC Crispin","year":"2005","unstructured":"Crispin\u00a0JC, Martinez-Banos\u00a0D, Alcocer-Varela\u00a0J (2005) Adult-onset Still disease as the cause of fever of unknown origin. Medicine 84(6):331\u2013337. https:\/\/doi.org\/10.1097\/01.md.0000188009.47085.76","journal-title":"Medicine"},{"issue":"5","key":"1522_CR63","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.jaad.2018.05.020","volume":"79","author":"E Zuelgaray","year":"2018","unstructured":"Zuelgaray\u00a0E, Battistella\u00a0M, de Salle Chou\u00a0C et\u00a0al (2018) Increased severity and epidermal alterations in persistent versus evanescent skin lesions in adult-onset Still disease. J\u00a0Am Acad Dermatol 79(5):969\u2013971. https:\/\/doi.org\/10.1016\/j.jaad.2018.05.020","journal-title":"J Am Acad Dermatol"},{"key":"1522_CR64","doi-asserted-by":"publisher","first-page":"989777","DOI":"10.3389\/fmed.2022.989777","volume":"9","author":"JF Nies","year":"2022","unstructured":"Nies\u00a0JF, Schneider\u00a0U, Krusche\u00a0M (2022) Rare, rarer, lung involvement in adult-onset Still\u2019s disease: A\u00a0mini-review. Front Med 9:989777. https:\/\/doi.org\/10.3389\/fmed.2022.989777","journal-title":"Front Med"},{"key":"1522_CR65","doi-asserted-by":"publisher","first-page":"1759720X2110595","DOI":"10.1177\/1759720X211059598","volume":"13","author":"C Kedor","year":"2021","unstructured":"Kedor\u00a0C, Tomaras\u00a0S, Baeumer\u00a0D, Feist\u00a0E (2021) Update on the therapy of adult-onset Still\u2019s disease with a\u00a0focus on IL-1-inhibition: a\u00a0systematic review. Ther Adv Musculoskelet Dis 13:1759720X211059598. https:\/\/doi.org\/10.1177\/1759720X211059598","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"1522_CR66","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/2045-7022-4-41","volume":"4","author":"HD de Koning","year":"2014","unstructured":"de Koning\u00a0HD (2014) Schnitzler\u2019s syndrome: lessons from 281 cases. Clin Transl Allergy 4:41. https:\/\/doi.org\/10.1186\/2045-7022-4-41","journal-title":"Clin Transl Allergy"},{"issue":"6","key":"1522_CR67","doi-asserted-by":"publisher","first-page":"521","DOI":"10.3109\/03009742.2015.1071421","volume":"44","author":"E Mulla","year":"2015","unstructured":"Mulla\u00a0E, Neame\u00a0R (2015) Delayed development of the IgM paraprotein in Schnitzler\u2019s syndrome. Scand J Rheumatol 44(6):521\u2013522. https:\/\/doi.org\/10.3109\/03009742.2015.1071421","journal-title":"Scand J Rheumatol"},{"issue":"5","key":"1522_CR68","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1111\/all.12129","volume":"68","author":"A Simon","year":"2013","unstructured":"Simon\u00a0A, Asli\u00a0B, Braun-Falco\u00a0M et\u00a0al (2013) Schnitzler\u2019s syndrome: diagnosis, treatment, and follow-up. Allergy 68(5):562\u2013568. https:\/\/doi.org\/10.1111\/all.12129","journal-title":"Allergy"},{"issue":"1","key":"1522_CR69","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.jaci.2007.09.021","volume":"121","author":"JG Ryan","year":"2008","unstructured":"Ryan\u00a0JG, de Koning\u00a0HD, Beck\u00a0LA, Booty\u00a0MG, Kastner\u00a0DL, Simon\u00a0A (2008) IL\u20111 blockade in Schnitzler syndrome: ex vivo findings correlate with clinical remission. J\u00a0Allergy Clin Immunol 121(1):260\u2013262. https:\/\/doi.org\/10.1016\/j.jaci.2007.09.021","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"1522_CR70","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s13023-019-1117-2","volume":"14","author":"FS van Leersum","year":"2019","unstructured":"van Leersum\u00a0FS, Potjewijd\u00a0J, van Geel\u00a0M, Steijlen\u00a0PM, Vreeburg\u00a0M (2019) Schnitzler\u2019s syndrome\u2014a\u00a0novel hypothesis of a\u00a0shared pathophysiologic mechanism with Waldenstrom\u2019s disease. Orphanet J Rare Dis 14(1):151. https:\/\/doi.org\/10.1186\/s13023-019-1117-2","journal-title":"Orphanet J Rare Dis"},{"issue":"Suppl 6","key":"1522_CR71","doi-asserted-by":"publisher","first-page":"vi31","DOI":"10.1093\/rheumatology\/kez448","volume":"58","author":"M Kacar","year":"2019","unstructured":"Kacar\u00a0M, Pathak\u00a0S, Savic\u00a0S (2019) Hereditary systemic autoinflammatory diseases and Schnitzler\u2019s syndrome. Rheumatology 58(Suppl 6):vi31\u2013vi43. https:\/\/doi.org\/10.1093\/rheumatology\/kez448","journal-title":"Rheumatology"},{"issue":"12","key":"1522_CR72","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1002\/art.41030","volume":"71","author":"S Pathak","year":"2019","unstructured":"Pathak\u00a0S, Rowczenio\u00a0DM, Owen\u00a0RG et\u00a0al (2019) Exploratory Study of MYD88 L265P, Rare NLRP3 Variants, and Clonal Hematopoiesis Prevalence in Patients With Schnitzler Syndrome. Arthritis Rheumatol 71(12):2121\u20132125. https:\/\/doi.org\/10.1002\/art.41030","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"1522_CR73","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/j.1365-2133.2007.08251.x","volume":"158","author":"K Claes","year":"2008","unstructured":"Claes\u00a0K, Bammens\u00a0B, Delforge\u00a0M, Evenepoel\u00a0P, Kuypers\u00a0D, Vanrenterghem\u00a0Y (2008) Another devastating complication of the Schnitzler syndrome: AA amyloidosis. Br J Dermatol 158(1):182\u2013184. https:\/\/doi.org\/10.1111\/j.1365-2133.2007.08251.x","journal-title":"Br J Dermatol"},{"issue":"7","key":"1522_CR74","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s00256-014-1857-y","volume":"43","author":"BD Niederhauser","year":"2014","unstructured":"Niederhauser\u00a0BD, Dingli\u00a0D, Kyle\u00a0RA, Ringler\u00a0MD (2014) Imaging findings in 22\u00a0cases of Schnitzler syndrome: characteristic para-articular osteosclerosis, and the \u201chot knees\u201d sign differential diagnosis. Skelet Radiol 43(7):905\u2013915. https:\/\/doi.org\/10.1007\/s00256-014-1857-y","journal-title":"Skelet Radiol"},{"issue":"7-8","key":"1522_CR75","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1080\/08916934.2019.1680649","volume":"52","author":"L Alix","year":"2019","unstructured":"Alix\u00a0L, Neel\u00a0A, Cador\u00a0B et\u00a0al (2019) Diagnostic value of 18\u2011F fluorodeoxyglucose PET\/CT and bone scan in Schnitzler syndrome. Autoimmunity 52(7-8):264\u2013271. https:\/\/doi.org\/10.1080\/08916934.2019.1680649","journal-title":"Autoimmunity"},{"issue":"10","key":"1522_CR76","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.autrev.2014.08.031","volume":"13","author":"A Neel","year":"2014","unstructured":"Neel\u00a0A, Henry\u00a0B, Barbarot\u00a0S et\u00a0al (2014) Long-term effectiveness and safety of interleukin\u20111 receptor antagonist (anakinra) in Schnitzler\u2019s syndrome: a\u00a0French multicenter study. Autoimmun Rev 13(10):1035\u20131041. https:\/\/doi.org\/10.1016\/j.autrev.2014.08.031","journal-title":"Autoimmun Rev"},{"issue":"6","key":"1522_CR77","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1016\/j.jaci.2019.12.909","volume":"145","author":"K Krause","year":"2020","unstructured":"Krause\u00a0K, Bonnekoh\u00a0H, Ellrich\u00a0A et\u00a0al (2020) Long-term efficacy of canakinumab in the treatment of Schnitzler syndrome. J\u00a0Allergy Clin Immunol 145(6):1681\u20131686 e5. https:\/\/doi.org\/10.1016\/j.jaci.2019.12.909","journal-title":"J Allergy Clin Immunol"},{"key":"1522_CR78","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1750-1172-5-38","volume":"5","author":"D Lipsker","year":"2010","unstructured":"Lipsker\u00a0D (2010) The Schnitzler syndrome. Orphanet J Rare Dis 5:38. https:\/\/doi.org\/10.1186\/1750-1172-5-38","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"1522_CR79","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1016\/j.jaip.2021.01.024","volume":"9","author":"H Bonnekoh","year":"2021","unstructured":"Bonnekoh\u00a0H, Frischbutter\u00a0S, Roll\u00a0S, Maurer\u00a0M, Krause\u00a0K (2021) Tocilizumab treatment in patients with Schnitzler syndrome: An open-label study. J\u00a0Allergy Clin Immunol Pract 9(6):2486\u20132489 e4. https:\/\/doi.org\/10.1016\/j.jaip.2021.01.024","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"1522_CR80","doi-asserted-by":"publisher","first-page":"704","DOI":"10.55563\/clinexprheumatol\/1r3i7i","volume":"39","author":"A Paladini","year":"2021","unstructured":"Paladini\u00a0A, Vitale\u00a0A, Frediani\u00a0B, Cantarini\u00a0L (2021) Resolution of Schnitzler\u2019s syndrome after haematopoietic stem cell transplantation. Clin Exp Rheumatol 39(3):704. https:\/\/doi.org\/10.55563\/clinexprheumatol\/1r3i7i","journal-title":"Clin Exp Rheumatol"},{"issue":"11","key":"1522_CR81","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1136\/annrheumdis-2013-204991","volume":"74","author":"R Levy","year":"2015","unstructured":"Levy\u00a0R, Gerard\u00a0L, Kuemmerle-Deschner\u00a0J et\u00a0al (2015) Phenotypic and genotypic characteristics of cryopyrin-associated periodic syndrome: a\u00a0series of 136 patients from the Eurofever Registry. Ann Rheum Dis 74(11):2043\u20132049. https:\/\/doi.org\/10.1136\/annrheumdis-2013-204991","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"1522_CR82","first-page":"424","volume":"19","author":"M Yamaguchi","year":"1992","unstructured":"Yamaguchi\u00a0M, Ohta\u00a0A, Tsunematsu\u00a0T et\u00a0al (1992) Preliminary criteria for classification of adult Still\u2019s disease. J\u00a0Rheumatol 19(3):424\u2013430 (https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1578458)","journal-title":"J Rheumatol"},{"key":"1522_CR83","unstructured":"Kedor CFE Adulter Morbus Still \u2013 Neues zur Diagnostik und Therapie \u2013 Adult-Onset Still\u2019s Disease: New Developments in Diagnostics and Treatment. Thieme"},{"issue":"Suppl 1","key":"1522_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00393-022-01276-4","volume":"81","author":"S Vordenbaumen","year":"2022","unstructured":"Vordenbaumen\u00a0S, Feist\u00a0E, Rech\u00a0J et\u00a0al (2022) DGRh S2e guidelines : Diagnostic and treatment of adult-onset Still\u2019s disease (AOSD). Z\u00a0Rheumatol 81(Suppl 1):1\u201320. https:\/\/doi.org\/10.1007\/s00393-022-01276-4","journal-title":"Z Rheumatol"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-024-01522-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00393-024-01522-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-024-01522-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T11:06:03Z","timestamp":1717412763000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00393-024-01522-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,27]]},"references-count":84,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["1522"],"URL":"https:\/\/doi.org\/10.1007\/s00393-024-01522-x","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,27]]},"assertion":[{"value":"24 April 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"A.\u00a0Pankow: Vortrag- und Beratungst\u00e4tigkeiten: Sobi, Novartis, Lilly, AbbVie, AstraZeneca. M.\u00a0Krusche: Vortrag- und Beratungst\u00e4tigkeiten: Sobi, Novartis, Sanofi, Roche\/Chugai.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patient\/-innen zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern\/Vertreterinnen eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}